Literature DB >> 12407121

Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants.

Patricia Sánchez1, Juan Francisco Linares, Beatriz Ruiz-Díez, Ester Campanario, Alfonso Navas, Fernando Baquero, José L Martínez.   

Abstract

Overproduction of multidrug resistance (MDR) efflux pumps is involved in the resistance to a wide range of compounds in bacteria. These determinants extrude antibiotics, but also bacterial metabolites like quorum-sensing signals. Non-regulated extrusion of bacterial metabolites might produce a metabolic burden, so that MDR-overproducing mutants could have a reduced fitness when compared with their parental strains. To test such a possibility, we have compared the behaviour of two MDR Pseudomonas aeruginosa in vitro selected mutants (nalB and nfxB) with their isogenic parental strain with respect to some properties with potential relevance for the survival in the environment and the virulence of this bacterial species. Overproduction of the MDR determinants MexABOprM (nalB mutant) and MexCDOprJ (nfxB mutant) decreased the survival in water, the production of phenazines and proteases, and the virulence (using a Caenorhabditis elegans model system) of the P. aeruginosa mutants. In contrast, the capability of forming biofilms was not impaired. The simple models tested in the present work can enable the analysis of the fitness of large numbers of antibiotic-resistant bacteria by using more realistic approaches than the in vitro competition assays currently used.

Entities:  

Mesh:

Year:  2002        PMID: 12407121     DOI: 10.1093/jac/dkf185

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  65 in total

Review 1.  Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors:  José L Martínez; Fernando Baquero
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

2.  Caenorhabditis elegans as a model to determine fitness of antibiotic-resistant Salmonella enterica serovar typhimurium.

Authors:  Wilhelm Paulander; Alexandra Pennhag; Dan I Andersson; Sophie Maisnier-Patin
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

3.  The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump.

Authors:  Patricia Sanchez; Eduardo Moreno; Jose L Martinez
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

4.  Antibiotics as intermicrobial signaling agents instead of weapons.

Authors:  J F Linares; I Gustafsson; F Baquero; J L Martinez
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-05       Impact factor: 11.205

5.  LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis.

Authors:  Silvia Buroni; Giulia Manina; Paola Guglierame; Maria Rosalia Pasca; Giovanna Riccardi; Edda De Rossi
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

6.  nalD encodes a second repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa.

Authors:  Yuji Morita; Lily Cao; Virginia C Gould; Matthew B Avison; Keith Poole
Journal:  J Bacteriol       Date:  2006-10-06       Impact factor: 3.490

7.  Quorum sensing and multidrug transporters in Escherichia coli.

Authors:  Shirley Yang; Christopher R Lopez; E Lynn Zechiedrich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-07       Impact factor: 11.205

8.  Fluoroquinolone-resistant mutants of Burkholderia cepacia.

Authors:  C F Pope; S H Gillespie; J R Pratten; T D McHugh
Journal:  Antimicrob Agents Chemother       Date:  2007-12-26       Impact factor: 5.191

9.  Structural and functional analysis of SmeT, the repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF.

Authors:  Alvaro Hernández; María J Maté; Patricia C Sánchez-Díaz; Antonio Romero; Fernando Rojo; José L Martínez
Journal:  J Biol Chem       Date:  2009-03-26       Impact factor: 5.157

10.  Metabolic compensation of fitness costs associated with overexpression of the multidrug efflux pump MexEF-OprN in Pseudomonas aeruginosa.

Authors:  Jorge Olivares; Carolina Álvarez-Ortega; José Luis Martinez
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.